Progentec Diagnostics is classified as operating in the Medical Laboratories industry, NAICS Code 621511.
Investor Activity
Progentec Diagnostics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
November 21, 2018
7
100%
$3 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Progentec Diagnostics is developing and marketing.
Progentec Diagnostics doesn't have any recent trademark applications, indicating Progentec Diagnostics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
LUPUSCORNER Business consulting and management in the field of clinical trials, namely, strategic planning, patient recruitment services and marketing, and tracking and maintenance of clinical data; Public advocacy to promote awareness of preventative measures and treatments, of improved healthcare quality and efficiency, and of scientific, research, and medical advances made possible through clinical research; and Promoting technical and scientific investigation, research, and experimentation in the field of advancement of the application of scientific discovery in connection with pharmaceuticals, diagnostic tools, biomarkers and medical devices
07/18/2019
PROGENTEC DIAGNOSTICS Providing access to a computer database; providing on-line forums for transmission of messages among computer and mobile device users concerning patient, doctor and caregiver information in order to generate, manage and share medical information; and provision of access to databases
01/11/2019
See all trademarks and details in the Full Report.
Market Share of Progentec Diagnostics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Progentec Diagnostics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Progentec Diagnostics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Progentec Diagnostics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.